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Summary. A wireless Body Sensor Node (BSN) and its operations are
presented. The BSN comprises all the necessary components (i.e., an-
tenna, electronics, batteries and bio-sensor) to allow continuous moni-
toring of physiological data. In vitro characterization validates the simu-
lated performances, while in vivo experiment shows the capability of the
system for real life telemedicine applications.
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1 Introduction
Wireless implantable systems promise large improvements in patients’ care and
quality of life. For this purpose, small biocompatible devices have been recently
presented for different applications such as pH monitoring [1], gastro-intestinal
tract exploration [2, 3] or cardiovascular pressure control [4]. In this work we
present a complete Body Sensor Node which has been tested in vitro and ap-
plied in vivo in a porcine animal for local temperature monitoring. The system
performs data telemetry with an external Base Station in the Medical Device
Radiocommunications Service band (MedRadio, 401-406 MHz) [5] and the In-
dustrial, Scientific and Medical band (ISM, 2.4-2.5 GHz).
2 Body Sensor Node
The proposed BSN aims at a high system integration of all its components,
namely: the Multilayered Spiral Antenna (MSA), the electronics (the RF transceiver
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and the Digital Signal Processor), the batteries and the bio-sensor. Fig. 1 de-
picts the complete packaging of the device. All the elements fit in a biocompatible
cylindrical housing which measures 10 x 32 [mm].
Multilayered Spiral Antenna
electronics
batteries
sensor
Fig. 1: Complete packaging of the proposed BSN. The biocompatible casing is in light
gray. As a possible sensor, the driver and rotor for glucose microviscometer
described in [6] are illustrated.
The MSA consists in a conformal radiator whose main resonating element is
a three dimensional spiral metallization developed on a pyramidal assembly as
described in [7, 8]. Polyetheretherketones (PEEK) was used for the biocompat-
ible housing, as it is very easy to machine and its biocompatible characteristics
are well established [9, 10]. The housing thickness (0.8 mm) was selected to im-
prove the electromagnetic radiation of the implanted radiator in agreement with
the results reported in [11]. The MSA has dual band capabilities working in
both the MedRadio and the ISM bands and its radiation performances (maxi-
mum gain equal to -29.4 and -17.7 dBi in the lower and higher frequency ranges,
respectively) provide a robust communication link for applications targeting a
minimum working range of 2 m.
The electronics components were assembled on a flexible Printed Circuit
Board (PCB) [12] to fit in the small available volume. The RF communication
is provided by an ultra-low power Integrated Circuit (IC), the ZL70101 [13]
manufactured by Zarlink, operating in both the MedRadio and ISM bands. The
BSN operations are executed by an ultra-low power digital signal processor: the
Ezairo 5900 manufactured by ON Semiconductor. Four coin type 377 batter-
ies (1.5 V/ 27 mAh), manufactured by Energizer, were selected to provide the
required power supply.
The conception of the proposed BSN gives a broad freedom regarding the
monitoring device or bio-actuator to be included. The front-end electronics to
drive the glucose microviscometer presented in [6] and the potentionstat de-
scribed in [14] are just examples of possible sensors.
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3 Power Consumption
In order to reduce the power requirements and to extend the life time of the
BSN, the system is kept in a sleeping state. In this condition only the 2.45 GHz
wake-up part of the transceiver is active and the power consumption is 2 µW. A
signal received in the ISM band wakes up the IC; subsequently, the measurements
are performed and the bidirectional communication occurs in the MedRadio fre-
quency spectrum. Considering the TMP112 temperature sensor from Texas In-
struments (used in the in vivo experiment), the total active phase lasts 430 ms
and consumes 15.7 mW. If one measurement is taken every 5 minutes, the em-
bedded batteries provide a life time of 284 days. The power ratio of each part of
the BSN is depicted in Fig. 6 (RF 91.9%, DSP 8.0%, sensor 0.1%). The RF por-
tion can be separated in the actual power used to transmit data (RFTX=2.7%),
to establish the MedRadio communication channel (RFest=14.6%) and to reserve
the channel until the data are ready to be sent (RFch=74.6%), as illustrated in
Fig. 2.
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Fig. 2: Power consumption repartition among the different components of the BSN
during the active phase.
Comparing the performances of implantable devices with telemetry capabil-
ities is not an easy task as many different conditions (working frequency, data
rate, duty cycle dimension, implant location, purpose, power supply) can be
considered. In Fig. 3 one can notice the good compromise of the proposed BSN
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among volume occupation, power consumption and life time when compared to
other implantable systems1.
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Fig. 3: Graphical comparison of active implantable devices with far field (blue) and
near field (red) communication capability: flourescent-based sens. [15], pace-
maker [16], glucose [17], pressure [18], ethanol [19], gastro-int. tract expl. [3],
Pill Cam [2], Animal telemetry [20] and our BSN. The size of the bubble re-
flects indicated the power consumption computed as the ration between life
time and the battery supplies.
4 In Vitro Characterization
In vitro tests were performed in order to check the functioning of the realized
device and validate the MSA radiation characteristic. The BSN was inserted in
a liquid body phantom. The latter has dielectric properties equivalent to the
human muscle tissue and has a cylindrical shape (80 x 110 [mm]). Outdoor test
were carried out to assess the capability of the MedRadio communication link
(as illustrated in Fig. 4-(a)), while the wake-up performances in the 2.45 GHz
ISM band were verified in an anechoic chamber.
Maximum working ranges, reported in Fig. 4-(b), confirmed the simulated
performances of the MSA. Considering the power link budget characteristics
of the IC ZL70101 and the Base Station provided by Zarlink, the maximum
registered ranges correspond to antenna gain values equal to -30.5 and -18.6 dBi
in the MedRadio and ISM bands, respectively. These values, which take into
account the mismatch and the losses within the electronics assembly, closely
agree with the predicted characteristics, i.e., -29.4 and -17.7 dBi.
1 The selected implantable sensors are only chosen to show examples of different ap-
plications as the list is by no means exhaustive.
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Fig. 4: In vitro characterization: (a) outdoor communication tests and (b) maximum
registered ranges for both working frequencies.
5 In Vivo Experiment
Two BSNs were implanted in a large animal model (Go¨ttingen minipigs) chosen
for the similarity between their and the human tissues. A temperature sensor
was included into the BSNs to study the correlation between local temperature
and the healing process of a deep wound in the settings of a cultured epidermal
autograft. In fact, it has been observed that the temperature has an important
impact on epidermal stem cell behavior in vitro [21].
Fig. 5: Implantation, in accordance to all ethical considerations and the regulatory
issues related to animal experiments, of the two BSNs at different depths. A
subcutaneous location (5 mm deep) and an intra-muscular one (30 mm deep),
were chosen.
In vivo experiment lasted for 15 consecutive days. During this period the
animal dwelled most of the time in a farm and periodically, it was taken away
for a follow-up at the hospital. Fig. 6 shows the registered temperatures during
one of these follow-ups. Values measured by a rectal probe are also reported to
appreciate the effect of the placement of the two BSNs.
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Fig. 6: Measured temperature values at the hospital.
While being at the farm, the animal was maintained indoor in a cage of
dimensions 1.3 x 2.7 [m]. In order not to interfere with the farm daily life (feeding
of the animals, cleaning, etc.), the Base Station was placed in the mansard above
the cage room at a distance of 2.5 m.
The overall performances during the entire test period are reported in
Table 1. During the 2696 interrogations between each BSN and the external
Base Station the relative number of failed communications are 5.82% and 16.10%
for the subcutaneous and intra-muscular BSN, respectively. From the point of
view of communication protocol, three sources of error are identified in Table 1:
MedRadio, ISM and firmware. One can appreciate that the data transmission
in the MedRadio was found to be the most critical on for the deepest sen-
sor (errMedRadio=12.46%), while the wake-up communication showed a relative
number of errors errISM lower than 5% for both BSNs. Almost negligible prob-
lems were caused by the driving firmware (errfirmware <0.2%). Explanations for
the registered errors have been found observing the pig activity in the cage and
the consequent relative positions between the BSNs and the Base Station.
Table 1: Communication Performances during the In Vivo Experiment.
BSN Number of errMedRadio errfirmware errISM errtot
Measurements [%] [%] [%] [%]
intra-muscular 2696 12.46 0.00 3.63 16.09
subcutaneous 2696 1.67 0.11 4.04 5.82
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6 Conclusion
This work presented the operation of a complete wireless Body Sensor Node.
The node integrates all the necessary components in a cylindrical volume
(10 x 32 [mm]). Communication with an external Base Station placed in a few
meters working range (up to 14 m) has been proven. The results obtained by
the in vitro and in vivo tests confirm the promising capabilities of the proposed
BSN and pave the way for future research oriented to the making of complete
telemedicine systems.
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